tiprankstipranks
Trending News
More News >
Invex Therapeutics Ltd. (AU:IXC)
ASX:IXC
Australian Market

Invex Therapeutics Ltd. (IXC) Technical Analysis

Compare
2 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Invex Therapeutics Ltd.’s (IXC) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Invex Therapeutics Ltd. is a Buy.
Invex Therapeutics Ltd.’s (IXC) 20-Day exponential moving average is 0.12, while Invex Therapeutics Ltd.’s (IXC) share price is AU$0.12, making it a Sell.
Invex Therapeutics Ltd.’s (IXC) 50-Day exponential moving average is 0.12, while Invex Therapeutics Ltd.’s (IXC) share price is AU$0.12, making it a Sell.

Invex Therapeutics Ltd. (IXC) Pivot Points

Mar 14, 2026, 02:16 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.09
0.10
0.10
0.11
0.12
0.13
0.13
Fibonacci
0.10
0.11
0.11
0.11
0.12
0.12
0.13
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Invex Therapeutics Ltd. (IXC) Moving Averages

Mar 14, 2026, 02:16 PM
Period
Simple
Exponential
MA5
0.11Sell
0.11Sell
MA10
0.11Sell
0.11Sell
MA20
0.12Sell
0.12Sell
MA50
0.12Sell
0.12Sell
MA100
0.12Sell
0.12Sell
MA200
0.11Sell
0.11Sell
Invex Therapeutics Ltd.’s (IXC) 10-Day exponential moving average is 0.11, while Invex Therapeutics Ltd.’s (IXC) share price is AU$0.12, making it a Sell.
Invex Therapeutics Ltd.’s (IXC) 100-Day exponential moving average is 0.12, while Invex Therapeutics Ltd.’s (IXC) share price is AU$0.12, making it a Sell.
Invex Therapeutics Ltd.’s (IXC) stock price is AU$0.12 and Invex Therapeutics Ltd.’s (IXC) 50-day simple moving average is 0.12, creating a Sell signal.
Invex Therapeutics Ltd.’s (IXC) stock price is AU$0.12 and Invex Therapeutics Ltd.’s (IXC) 100-day simple moving average is 0.12, creating a Sell signal.
Invex Therapeutics Ltd.’s (IXC) stock price is AU$0.12 and Invex Therapeutics Ltd.’s (IXC) 200-day simple moving average is 0.11, creating a Sell signal.

Invex Therapeutics Ltd. (IXC) Technical Indicators

Mar 14, 2026, 02:16 PM
Name
Value
Implied Action
RSI (14)
19.99
Buy
STOCH (9,6)
8.33
Buy
STOCHRSI (14)
6.67
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
20.37
Neutral
Williams %R
-120.00
Buy
CCI (14)
-200.00
Buy
ATR (14)
0.01
-
Ultimate Oscillator
37.86
Neutral
ROC
-16.67
Sell
Invex Therapeutics Ltd.’s (IXC) Relative Strength Index (RSI) is 19.99, creating a Buy signal.
Invex Therapeutics Ltd.’s (IXC) Trend Strength Indicator (ADX) is 20.37, creating a Neutral signal.
Invex Therapeutics Ltd.’s (IXC) Commodity Channel Index (CCI) is -200.00, creating a Buy signal.
Invex Therapeutics Ltd.’s (IXC) Price Rate of Change (ROC) is -16.67, creating a Sell signal.

FAQ

Is IXC a Buy, Hold, or Sell?
Based on IXC’s technical indicators, IXC is a Sell.
    What is IXC’s RSI (14)?
    IXC’s RSI (14) is 19.99, which suggests IXC is a Buy.
      What is IXC’s MACD?
      IXC’s MACD is >-0.01, which suggests IXC is a Buy.
        What is IXC’s 5-day moving average?
        IXC’s 5-day moving average is 0.11, which suggests IXC is a Sell.
          What is IXC’s 20-day moving average?
          IXC 20-day moving average is 0.12, which suggests IXC is a Sell.
            What is IXC’s 50-day moving average?
            IXC’s 50-day moving average is 0.12, which suggests IXC is a Sell.
              What is IXC’s 200-day moving average?
              IXC’s 200-day moving average is 0.11, which suggests IXC is a Sell.
                What is IXC’s Williams % R (14)?
                IXC’s Williams % R (14) is -120.00, which suggests IXC is a Buy.
                  What is IXC’s CCI (14)?
                  IXC’s CCI (14) is -200.00, which suggests IXC is a Buy.
                    What is the share price of Invex Therapeutics Ltd.?